Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 223,864,669 papers from all fields of science
Search
Sign In
Create Free Account
methylbenzoprim
Known as:
2,4-Pyrimidinediamine, 6-ethyl-5-(4-(methyl(phenylmethyl)amino)-3-nitrophenyl)-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Folic Acid Antagonists
Pyrimidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Structural studies on bioactive compounds. 39. Biological consequences of the structural modification of DHFR-inhibitory 2,4-diamino-6-(4-substituted benzylamino-3-nitrophenyl)-6-ethylpyrimidines…
M. Richardson
,
K. Croughton
,
C. Matthews
,
M. Stevens
Journal of Medicinal Chemistry
2004
Corpus ID: 35333978
Benzimidazole-N-oxide modifications of potent lipophilic dihydrofolate reductase (DHFR) inhibitors (e.g., methylbenzoprim 1 and…
Expand
2001
2001
Investigations on the biological properties of the lipophilic DHFR-inhibitory benzoprims reveal non-folate modes of action and opportunities for anti-cancer drug design.
K. Croughton
,
C. Matthews
,
R. Griffin
,
M. Stevens
Anti-Cancer Drug Design
2001
Corpus ID: 37423926
Dichlorobenzoprim and methylbenzoprim were the lead compounds to emerge from investigations on a series of lipophilic 2,4-diamino…
Expand
2001
2001
Novel pharmacology of the lipophilic antifolate methylbenzoprim.
K. Croughton
2001
Corpus ID: 76745625
1998
1998
Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines.
C. Robson
,
K. Wright
,
P. Twentyman
,
P. Lambert
,
R. Griffin
Biochemical Pharmacology
1998
Corpus ID: 41882455
1997
1997
Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents.
C. Robson
,
M. Meek
,
+4 authors
R. Griffin
Journal of Medicinal Chemistry
1997
Corpus ID: 28874687
Twelve novel 2,4-diamino-5-(4'-benzylamino)- and 2,4-diamino-5[4'-(N-methylbenzylamino)-3'-nitrophenyl]-6-ethylp yrimidines…
Expand
1992
1992
Structural studies on bio-active compounds. 20. Molecular modeling and crystallographic studies on methylbenzoprim, a potent inhibitor of dihydrofolate reductase.
B. Denny
,
N. Ringan
,
+4 authors
M. Stevens
Journal of Medicinal Chemistry
1992
Corpus ID: 304594
Methylbenzoprim (MBP) is a potent inhibitor of dihydrofolate reductase, which is more selective for mammalian than bacterial…
Expand
1992
1992
Structural studies on bio-active compounds. Part 21. Acid-promoted debenzylations in antitumour 2,4-diamino-5-[4-(N-alkylbenzylamino)-3-nitrophenyl]-6-ethylp yrimidines.
R. Griffin
,
M. Stevens
Anti-Cancer Drug Design
1992
Corpus ID: 41202535
Methylbenzoprim and ethylbenzoprim undergo debenzylation in hydrochloric acid. Two reaction mechanisms are proposed to explain…
Expand
1990
1990
NMR studies of multiple conformations in complexes of Lactobacillus casei dihydrofolate reductase with analogues of pyrimethamine.
B. Birdsall
,
S. Tendler
,
+6 authors
M. Stevens
Biochemistry
1990
Corpus ID: 26512363
1H and 19F NMR signals from bound ligands have been assigned in one- and two-dimensional NMR spectra of complexes of…
Expand
1990
1990
Structural studies on bio-active compounds. Part 16. Synthesis and properties of sterically-constrained analogues of methylbenzoprim, a new dihydrofolate reductase inhibitor.
R. Griffin
,
M. Stevens
,
C. Sansom
Anti-Cancer Drug Design
1990
Corpus ID: 40275334
The new lipophilic dihydrofolate reductase inhibitor methylbenzoprim is a flexible substituted 2,4-diamino-5-arylpyrimidine…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE